Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Safety, Blood Brain Barrier Permeability and Potential Efficacy of Etanercept for Aneurysmal Subarachnoid Hemorrhage

NCT01865630 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT01865630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01865630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Safety, Blood Brain Barrier Permeability and Potential Efficacy of Etanercept for Aneurysmal Subarachnoid Hemorrhage
Lead sponsor
Unity Health Toronto
Phase
Phase 1
Overall status
Withdrawn
Start date
January 31, 2021
Completion date
January 31, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subarachnoid hemorrhage, aneurysmal